Radiation inducible molecular targets identification after single and fractionated radiation in prostate carcinoma

Ended Purchase Order Awarded Last action

Contract number
HHSN261201800265P
Awardee
Awarding agency
Obligated
$38,200

Award facts

Opportunity
Contract value 100% obligated
$38,200.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Brookline, NH 03033, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Cancer Institute awarded a purchase order to Gryphon Scientific, LLC valued at $38,200 for radiation inducible molecular targets identification after single and fractionated radiation in prostate carcinoma, with an award date of April 9, 2018 and ultimate completion date of April 9, 2019. Work is performed in Brookline, New Hampshire under firm fixed price terms with no small business set-aside.

Quick answers

Who was awarded contract HHSN261201800265P?

HHSN261201800265P was awarded to Gryphon Scientific, LLC by National Cancer Institute (National Institutes of Health) on April 9, 2018.

How much is contract HHSN261201800265P worth?

The government has obligated $38,200 on HHSN261201800265P.

Was contract HHSN261201800265P competed?

The extent of competition for HHSN261201800265P was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login